NewsRamp Science, Exploration and Discovery Podcast
Streamlined Development Pathway for GEO-MVA Vaccine in Europe
Jun 16, 2025
2:21
-(0)
About this episode
GeoVax Labs, Inc. has received positive guidance from the EMA for their GEO-MVA vaccine, allowing for a single Phase 3 trial to evaluate efficacy against Mpox and smallpox. This streamlined process could accelerate regulatory approval, providing a critical new vaccine source amidst the Mpox emergency.
Comments
Rate this episode
Episode Details
- Author
- NewsRamp
- Show Type
- full
- Audio Format
- audio/mpeg